Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 5/2014

01-10-2014

Pituitary incidentalomas

Authors: George A. Scangas, Edward R. Laws Jr.

Published in: Pituitary | Issue 5/2014

Login to get access

Abstract

Introduction

Incidentally discovered pituitary adenomas are more and more commonly encountered in endocrinology and neurosurgical practices. Often they present as difficult problems in management strategies. This review summarizes the latest evidence and opinions in a variety of settings in which incidental pituitary tumors are discovered, including subclinical pituitary tumor apoplexy.

Methods

A systematic literature review was accomplished using a spectrum of contemporary sources for information regarding pituitary incidentalomas.

Results

Up to date findings regarding epidemiology, definition of pituitary incidentaloma, patient evaluation, diagnostic studies, and management are presented.

Conclusions

Current experience from a multidisciplinary pituitary center is presented, with indications for treatment and longitudinal care of these challenging patients.
Literature
1.
2.
Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:894–904PubMedCrossRef
3.
Molitch ME (2008) Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 37:151–171 xiPubMedCrossRef
4.
Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314:287–291PubMedCrossRef
5.
Vernooij MW, Ikram A, Tanghe HL et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828PubMedCrossRef
6.
Hall W, Luciano M, Doppman J et al (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120(10):817–820PubMedCrossRef
7.
Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten year experience in 2,598 patients. J Clin Endocrinol Metabol 96(6):1633–1641CrossRef
8.
Buurman H, Saeger W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef
9.
Kim J-H, Seo J-S, Lee B-W et al (2007) The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases. J Korean Med Sci 22(Suppl.):S61–S65PubMedCentralPubMedCrossRef
10.
Auer RN, Alakija P, Sutherland GR (1996) Asymptomatic large pituitary adenomas discovered at autopsy. Surg Neurol 46:28–31PubMedCrossRef
11.
12.
McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491PubMed
13.
14.
Bancos I, Natt N, Murad MH, Montori VM (2012) Evidence-based endocrinology: illustrating its principles in the management of patients with pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 26(1):9–19PubMedCrossRef
15.
Anagnostis P, Adamidou F, Polyzos S et al (2011) Pituitary incidentalomas: a single-centre experience. Int J Clin Pract 65(2):172–177PubMedCrossRef
16.
Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884–891PubMedCrossRef
17.
Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study. Clin Endocrinol (Oxf) 51:109–113CrossRef
18.
Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W (1990) The ‘incidentaloma’ of the pituitary gland. Is neurosurgery required? JAMA 263:2772–2776PubMedCrossRef
19.
Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:123–127PubMedCrossRef
20.
Fainstein Day P, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM et al (2004) Retrospective multicentric study of pituitary incidentalomas. Pituitary 7:145–148 (Erratum in Pituitary 14:198, 2011)PubMedCrossRef
21.
Donovan LE, Corenblum B (1995) The natural history of the pituitary incidentaloma. Arch Intern Med 155:181–183PubMedCrossRef
22.
23.
Freda PU, Post KD (1999) Differential Diagnosis of sellar masses. Endocrinol Metab Clin North Am 28:81–118PubMedCrossRef
24.
King JT Jr, Justice AC, Aron DC (1997) Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab 82:3625–3632PubMed
25.
26.
27.
28.
Molitch ME (1995) Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 80:3–6PubMed
29.
Semple PL, Jane JA Jr, Laws ER Jr (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61(5):956–961PubMedCrossRef
30.
Semple PL, Webb MK, de Villiers JC, Laws ER Jr (2005) Pituitary apoplexy. Neurosurgery 56(1):65–72PubMed
31.
Semple PL, de Villiers JC, Bowen RM, Lopes MBS, Laws ER Jr (2006) Pituitary apoplexy: do histological features influence the clinical presentation and outcome? J Neurosurg 104:931–937PubMedCrossRef
32.
Chanson P, Daujat F, Young J et al (2001) Normal pituitary hypertrophy as a frequent cause of pituitary incidentalomas: a followup study. J Clin Endocrinol Metab 86:3009–3015PubMedCrossRef
33.
Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Incidental pituitary adenomas. Neurosurg Focus 31(6):E18PubMedCrossRef
34.
Howlett T, Como J, Aron D (2000) Management of pituitary incidentalomas. A survey of British and American endocrinologists. Endocrinol Metab Clin North Am 29(1):223–230PubMedCrossRef
35.
Ahmed S, Elsheikh M, Stratton I et al (1999) Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50(5):561–567CrossRef
36.
Bates AS, Van’t Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment of acromegaly. Q J Med 86:293–299PubMed
37.
O’Brien T, O’Riordan DS, Gharib H, Scheithauer BW, Ebersold MJ, van Heerden JA (1996) Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. Neurosurgery 39:273–279PubMedCrossRef
38.
Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA (1987) Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4:205–211PubMed
39.
Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JA (1999) Classical pituitary apoplexy: clinical features management and outcome. Clin Endocrinol 51:181–188CrossRef
40.
Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P (2006) Pituitary apoplexy: retrospective review of 30 patients- is surgical intervention always necessary? Br J Neurosurg 20:379–385PubMedCrossRef
41.
Dekkers OM, Hammer S, de Keizer RJ, Roelfsema F, Schutte PJ, Smit JW et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156:217–224PubMedCrossRef
42.
Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA et al (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96:905–912PubMedCrossRef
43.
Nishizawa S, Ohta S, Yokoyama T, Uemura K (1998) Therapeutic strategy for incidentally found pituitary tumors (“pituitary incidentalomas”). Neurosurgery 43:1344–1350PubMed
44.
Igarashi T, Saeki N, Yamaura A (1999) Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors. Their natural history and surgical indications. Neurol Med Chir 39:592–599CrossRef
45.
Karavitaki N, Collison K, Halliday J et al (2007) What is the natural history of nonoperated, nonfunctioning pituitary adenomas? Clin Endocrinol 67:938–943CrossRef
46.
Oyama K, Sanno N, Tahara S et al (2005) Management of pituitary incidentalomas: according to a survey of pituitary incidentalomas in Japan. Semin Ultrasound CT MRI 26:47–50CrossRef
47.
Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667–675PubMedCrossRef
48.
Daly AF, Burlacu MC, Livadariu E et al (2007) The epidemiology and management of pituitary incidentalomas. Horm Res 68(suppl. 5):195–198PubMedCrossRef
Metadata
Title
Pituitary incidentalomas
Authors
George A. Scangas
Edward R. Laws Jr.
Publication date
01-10-2014
Publisher
Springer US
Published in
Pituitary / Issue 5/2014
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-013-0517-x

Other articles of this Issue 5/2014

Pituitary 5/2014 Go to the issue

OriginalPaper

Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism

OriginalPaper

Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson’s syndrome: diagnostic challenges

Erratum

Erratum to: Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists

OriginalPaper

Surgical management of pituicytomas: case series and comprehensive literature review

OriginalPaper

AZA-Deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors

OriginalPaper

Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits